Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In vitro functional characterization of a panel of non-fentanyl opioid new psychoactive substances
Marthe M. Vandeputte, Annelies Cannaert, Christophe P. Stove
Archives of Toxicology (2020) Vol. 94, Iss. 11, pp. 3819-3830
Closed Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Synthesis, Chemical Characterization, and μ-Opioid Receptor Activity Assessment of the Emerging Group of “Nitazene” 2-Benzylbenzimidazole Synthetic Opioids
Marthe M. Vandeputte, Katleen Van Uytfanghe, Nathan K. Layle, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 7, pp. 1241-1251
Open Access | Times Cited: 96
DARK Classics in Chemical Neuroscience: Etonitazene and Related Benzimidazoles
István Ujváry, Rachel Christie, Michael Evans‐Brown, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 7, pp. 1072-1092
Closed Access | Times Cited: 88
The Rise and Fall of Isotonitazene and Brorphine: Two Recent Stars in the Synthetic Opioid Firmament
Marthe M. Vandeputte, Alex J. Krotulski, Donna M Papsun, et al.
Journal of Analytical Toxicology (2021) Vol. 46, Iss. 2, pp. 115-121
Open Access | Times Cited: 57
Biased Agonism: Lessons from Studies of Opioid Receptor Agonists
Eamonn Kelly, Alexandra E. Conibear, Graeme Henderson
The Annual Review of Pharmacology and Toxicology (2022) Vol. 63, Iss. 1, pp. 491-515
Open Access | Times Cited: 48
Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017–2020: A Review
Amanda L A Mohr, Barry K. Logan, Melissa F. Fogarty, et al.
Journal of Analytical Toxicology (2022) Vol. 46, Iss. 6, pp. e116-e185
Open Access | Times Cited: 46
Mu-opioid receptor selective superagonists produce prolonged respiratory depression
Nicholas J. Malcolm, Barbara Palković, Daniel J. Sprague, et al.
iScience (2023) Vol. 26, Iss. 7, pp. 107121-107121
Open Access | Times Cited: 23
Pharmacologic Characterization of Substituted Nitazenes atμ,κ, andΔOpioid Receptors Suggests High Potential for Toxicity
Laura B. Kozell, Amy J. Eshleman, Katherine M. Wolfrum, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 389, Iss. 2, pp. 219-228
Open Access | Times Cited: 13
Isotonitazene, a synthetic opioid from an emerging family: The nitazenes
Jean-Joseph Bendjilali-Sabiani, Céline Eiden, Margot Lestienne, et al.
Therapies (2024) Vol. 79, Iss. 6, pp. 655-658
Closed Access | Times Cited: 11
In vitro structure–activity relationships and forensic case series of emerging 2-benzylbenzimidazole ‘nitazene’ opioids
Liam M. De Vrieze, Sara E. Walton, Eline Pottie, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 9, pp. 2999-3018
Open Access | Times Cited: 10
New and Emerging “Nitazene” Analogues Appearing in Medicolegal Death Investigations
Sara Walton, Donna M Papsun, Elisa N. Shoff, et al.
American Journal of Forensic Medicine & Pathology (2025)
Closed Access | Times Cited: 1
Isotonitazene: Fatal intoxication in three cases involving this unreported novel psychoactive substance in Switzerland
F. Mueller, Christian Bogdal, Bernhard Pfeiffer, et al.
Forensic Science International (2021) Vol. 320, pp. 110686-110686
Open Access | Times Cited: 53
Non-fentanyl new synthetic opioids – An update
Jolanta B. Zawilska, Piotr Adamowicz, Marta Kurpeta, et al.
Forensic Science International (2023) Vol. 349, pp. 111775-111775
Closed Access | Times Cited: 20
U-47700 and Its Analogs: Non-Fentanyl Synthetic Opioids Impacting the Recreational Drug Market
Michael H. Baumann, Graziella Tocco, Donna M Papsun, et al.
Brain Sciences (2020) Vol. 10, Iss. 11, pp. 895-895
Open Access | Times Cited: 43
Identification of psychedelic new psychoactive substances (NPS) showing biased agonism at the 5-HT2AR through simultaneous use of β-arrestin 2 and miniGαq bioassays
Eline Pottie, Peter Dedecker, Christophe P. Stove
Biochemical Pharmacology (2020) Vol. 182, pp. 114251-114251
Open Access | Times Cited: 41
Pharmacological characterization of novel synthetic opioids: Isotonitazene, metonitazene, and piperidylthiambutene as potent μ-opioid receptor agonists
Maria Antonietta De Luca, Graziella Tocco, Rafaela Mostallino, et al.
Neuropharmacology (2022) Vol. 221, pp. 109263-109263
Open Access | Times Cited: 28
Proliferation of Novel Synthetic Opioids in Postmortem Investigations After Core-Structure Scheduling for Fentanyl-Related Substances
Donna M Papsun, Alex J. Krotulski, Barry K. Logan
American Journal of Forensic Medicine & Pathology (2022) Vol. 43, Iss. 4, pp. 315-327
Closed Access | Times Cited: 26
Non-fentanyl-derived synthetic opioids emerging during recent years
Koutaro Hasegawa, Kayoko Minakata, Masako Suzuki, et al.
Forensic Toxicology (2022) Vol. 40, Iss. 2, pp. 234-243
Open Access | Times Cited: 25
In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl
Sabrine Bilel, Joaquim Azevedo Neto, Raffaella Arfè, et al.
Neuropharmacology (2022) Vol. 209, pp. 109020-109020
Open Access | Times Cited: 23
Metabolic characterization of the new benzimidazole synthetic opioids - nitazenes
Gajanan Raosaheb Jadhav, Pius S. Fasinu
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Brorphine—Investigation and quantitation of a new potent synthetic opioid in forensic toxicology casework using liquid chromatography‐mass spectrometry
Alex J. Krotulski, Donna M Papsun, Carolina Noble, et al.
Journal of Forensic Sciences (2020) Vol. 66, Iss. 2, pp. 664-676
Closed Access | Times Cited: 38
First Report on Brorphine: The Next Opioid on the Deadly New Psychoactive Substance Horizon?
Nick Verougstraete, Marthe M. Vandeputte, Cathelijne Lyphout, et al.
Journal of Analytical Toxicology (2020) Vol. 44, Iss. 9, pp. 937-946
Open Access | Times Cited: 37
Shape matters: The application of activity‐based in vitro bioassays and chiral profiling to the pharmacological evaluation of synthetic cannabinoid receptor agonists in drug‐infused papers seized in prisons
Lysbeth H. Antonides, Annelies Cannaert, Caitlyn Norman, et al.
Drug Testing and Analysis (2020) Vol. 13, Iss. 3, pp. 628-643
Open Access | Times Cited: 34
Detection of AP‐237 and synthetic cannabinoids on an infused letter sent to a German prisoner
Arianna Giorgetti, Pietro Brunetti, Susi Pelotti, et al.
Drug Testing and Analysis (2022) Vol. 14, Iss. 10, pp. 1779-1784
Open Access | Times Cited: 21
A New Synthetic Opioid Threat: A Comprehensive Review on MT-45
Sena Nur Kadem, Zeynep Arslan, Zeynep Türkmen
Forensic Science International (2025) Vol. 371, pp. 112479-112479
Closed Access
Characterization of recent non-fentanyl synthetic opioids via three different in vitro µ-opioid receptor activation assays
Marthe M. Vandeputte, Mattias Persson, Donna Walther, et al.
Archives of Toxicology (2022) Vol. 96, Iss. 3, pp. 877-897
Closed Access | Times Cited: 18
Page 1 - Next Page

Scroll to top